Lachnospiraceae

BacteriaBacillotaClostridiaEubacterialesLachnospiraceae
MCA-BAC-000004
TaxID: 186803 | Rank: family
Biology & Ecology
Biology
Gram Statusgram-positive
Oxygen Toleranceobligate anaerobe
Ecology
Primary Nichesgut
Reservoirhuman
Metabolites

No metabolite relationships documented for this taxon.

Clinical Profile
Pathobiont
yes no context dependent unknown
Clinical Rolesprotective commensal
Typical Specimenstool
Clinical Associations:
E2
E3 — Strong human clinical evidence E2 — Moderate human evidence E1 — Limited / preliminary
Lachnospiraceae relative abundance was significantly depleted in critically ill ICU patients compared to healthy controls (ANCOM-II p-adj<0.1), contributing to the loss of colonization resistance and gut dysbiosis during critical illness in a prospective cohort of 51 patients.
PMID: 36894652
D016638 Critical Illness D064806 Dysbiosis
E2
E3 — Strong human clinical evidence E2 — Moderate human evidence E1 — Limited / preliminary
Penalized ridge regression identified Lachnospiraceae as one of the most important families negatively associated with progressive Enterobacteriaceae enrichment between ICU days 1 and 3, consistent with a colonization resistance role against pathobiont expansion during critical illness.
PMID: 36894652
D016638 Critical Illness D064806 Dysbiosis
E1
E3 — Strong human clinical evidence E2 — Moderate human evidence E1 — Limited / preliminary
In a phase 1 FMT trial (n=10 anti-PD-1-refractory metastatic melanoma patients), both FMT donors who had achieved complete response to anti-PD-1 therapy were characterized by high Lachnospiraceae relative abundance in their stool microbiota; the paper explicitly characterizes this as a previously reported 'immunotherapy-favorable feature' of the gut microbiome associated with response to anti-PD-1 therapy.
PMID: 33303685
D000069467 Fecal Microbiota Transplantation D000069196 Gastrointestinal Microbiome D000082082 Immune Checkpoint Inhibitors D008545 Melanoma H00038 Melanoma
E1
E3 — Strong human clinical evidence E2 — Moderate human evidence E1 — Limited / preliminary
In a murine CDI model, susceptibility to C. difficile colonization following antibiotic treatment was associated with loss of the normal cecal microbial community (mainly Lachnospiraceae) and a relative increase in Enterobacteriaceae; disease severity was related to the recovery dynamics of these families, with more severe outcomes in mice where Lachnospiraceae failed to return post-antibiotic and Enterobacteriaceae continued to dominate.
PMID: 24503131
D004761 Enterocolitis Pseudomembranous H00338 Pseudomembranous colitis
E1
E3 — Strong human clinical evidence E2 — Moderate human evidence E1 — Limited / preliminary
Monocolonization of germ-free mice with a murine Lachnospiraceae isolate significantly reduced levels of C. difficile colonization and severity of colitis compared to mice monocolonized with a murine E. coli isolate, which had no protective effect, formally demonstrating a colonization resistance function for Lachnospiraceae family members against C. difficile intestinal invasion.
PMID: 24503131
D004761 Enterocolitis Pseudomembranous H00338 Pseudomembranous colitis
Last reviewed: 2026-04-03
Evidence Timeline
Related Taxa Shared Niche = same body site   Shared Risk = same vulnerable population